FDC-B1: a new monoclonal antibody directed against bovine follicular dendritic cells

F Mélot1, V Defaweux, O Jolois

  • 1Institute of Human Histology, University of Liège, Rue de Pitteurs, 20, B-4020 Liège, Belgium.

Insights

A new monoclonal antibody, FDC-B1, aids in identifying follicular dendritic cells (FDCs), crucial accessory cells involved in immune responses and prion disease pathogenesis. This antibody targets a specific 28 kDa antigen on FDCs in ruminant lymphoid organs.

Area of Science:

  • Immunology
  • Cell Biology
  • Veterinary Pathology

Background:

  • Follicular dendritic cells (FDCs) are accessory cells in lymphoid follicles, vital for humoral immunity.
  • FDCs play a significant role in prion diseases, serving as sites for prion protein expression and agent accumulation.
  • Accurate identification of FDCs is crucial for analyzing their distribution in both normal and pathological lymphoid tissues.

Purpose of the Study:

  • To report the production and characterization of a novel mouse monoclonal antibody, FDC-B1.
  • To identify a specific antigen recognized by FDC-B1 on follicular dendritic cells.
  • To evaluate the utility of FDC-B1 for identifying FDCs in ruminant lymphoid organs.

Main Methods:

  • Production of a mouse monoclonal antibody (FDC-B1) against bovine follicular dendritic cells.
  • Characterization of the antigen recognized by FDC-B1, including its molecular weight and expression pattern.
  • Testing the antibody's specificity for FDCs in ruminant lymphoid tissues.

Main Results:

  • The FDC-B1 antibody was successfully produced and characterized.
  • The antigen detected by FDC-B1 is exclusively expressed on the surface of FDCs in ruminant lymphoid organs.
  • The target antigen has an approximate molecular weight of 28 kDa.

Conclusions:

  • The FDC-B1 monoclonal antibody is a specific and useful tool for identifying follicular dendritic cells in ruminant lymphoid tissues.
  • This antibody facilitates the study of FDC distribution and their role in various conditions, including prion diseases.
  • The identified 28 kDa antigen provides a novel marker for FDC research.